Accordingly, loss-of-function mutations of the NF1 protein result in hyper-activation of RAS and, in combination with mutant BRAF protein, prevent oncogene-induced senescence during melanoma development by deregulating the PI3K and MAPK pathways [32]. This evidence concerns the gene BRAF and melanoma.